PatientsVille.com Logo

PatientsVille

Cymbalta Side Effects

Report Cymbalta Side Effects

If you experienced any harmful or unwanted effects of Cymbalta, please share your experience. This could help to raise awareness about Cymbalta side effects, identify uknown risks and inform health professionals and patients taking Cymbalta.

Examples: headache, dizziness


The most commonly reported Cymbalta side effects are:
Tiredness (76 reports)
Sexual Side Effects (53 reports)
Night Sweats (40 reports)
Sweats (26 reports)
Pancreatitis (22 reports)
Body Aches (22 reports)
Nausea (19 reports)
Insomnia (15 reports)
Shaking (12 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Cymbalta side effects . You can also compare Cymbalta side effects or view FDA reports.

Cymbalta Side Effects reported to FDA

The following Cymbalta reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Cymbalta on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 575 

Cerebrovascular Accident, Hyponatraemia
on Mar 03, 2014 Female from IL , 81 years of age, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: cerebrovascular accident, hyponatraemia. Cymbalta dosage: N/A.
Associated medications used:
  • Acamol
  • Clexane
  • Aerovent
  • Caltrate /00944201/
  • Eltroxin
  • Forteo
  • Losec
  • Optalgin
Patient was hospitalized.

Hepatitis C, Liver Disorder
Patient was taking Cymbalta. Patient felt the following Cymbalta side effects: hepatitis c, liver disorder on Mar 03, 2014 from CA Additional patient health information: Female , 65 years of age, was diagnosed with and. Cymbalta dosage: N/A.

Hepatic Enzyme Increased, Fatigue
Adverse event was reported on Mar 03, 2014 by a Female taking Cymbalta (Dosage: N/A) . Location: FR , 57 years of age, After Cymbalta was administered, patient encountered several Cymbalta side effects: hepatic enzyme increased, fatigue.

Gamma-glutamyltransferase Increased
on Mar 03, 2014 Female from FR , 59 years of age, was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: gamma-glutamyltransferase increased. Cymbalta dosage: N/A.
Associated medications used:


Homicidal Ideation, Suicidal Ideation, Off Label Use, Personality Change, Depression, Dry Mouth, Headache, Abdominal Pain Upper
on Feb 27, 2014 Female from US , 35 years of age, weighting 215.0 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: homicidal ideation, suicidal ideation, off label use, personality change, depression, dry mouth, headache, abdominal pain upper. Cymbalta dosage: N/A.

Tongue Geographic, Multiple Sclerosis, Leukoencephalopathy
Patient was taking Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: tongue geographic, multiple sclerosis, leukoencephalopathy on Feb 27, 2014 from FR Additional patient health information: Female , 38 years of age, was diagnosed with and. Cymbalta dosage: N/A.
Multiple concurrent drugs taken:

Stevens-johnson Syndrome
Adverse event was reported on Feb 27, 2014 by a Female taking Cymbalta (Dosage: N/A) . Location: CA , 50 years of age, Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: stevens-johnson syndrome.

Placental Insufficiency, Exposure During Pregnancy
on Feb 26, 2014 Female from DE , 32 years of age, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: placental insufficiency, exposure during pregnancy. Cymbalta dosage: 120 Mg, Qd.
Multiple prescriptions taken:

Disturbance In Attention, Feeling Hot, Chills, Hyperhidrosis, Impaired Work Ability, Thinking Abnormal, Paraesthesia, Visual Impairment, Back Pain
on Feb 25, 2014 Female from US , 49 years of age, was diagnosed with and was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: disturbance in attention, feeling hot, chills, hyperhidrosis, impaired work ability, thinking abnormal, paraesthesia, visual impairment, back pain. Cymbalta dosage: N/A.

Acne
Patient was taking Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: acne on Feb 24, 2014 from US Additional patient health information: Female , 45 years of age, weighting 140.0 lb, . Cymbalta dosage: 1 Dose 60 Mg Once Daily.

Oedema Peripheral
Adverse event was reported on Feb 25, 2014 by a Male taking Cymbalta (Dosage: 90 Mg, Qd) . Location: FR , 50 years of age, Patient felt the following Cymbalta side effects: oedema peripheral.
Multiple prescriptions taken: Patient was hospitalized.

Platelet Count Decreased, Transaminases Increased, Nausea
on Feb 24, 2014 Male from FR , 58 years of age, was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: platelet count decreased, transaminases increased, nausea. Cymbalta dosage: N/A.

Panic Attack, Psychomotor Hyperactivity, Vomiting, Dysphoria
on Feb 24, 2014 Female from FR , 26 years of age, weighting 127.9 lb, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: panic attack, psychomotor hyperactivity, vomiting, dysphoria. Cymbalta dosage: 60 Mg, Qd.
Associated medications used:
  • Neurontin (600 Mg, Tid)
  • Laroxyl (5 Df, Each Evening)
  • Imovane (7.5 Mg, Qd)
  • Transipeg /00754501/ (2 Df, Prn)
  • Durogesic (1 Df, Every 72h)
  • Xanax (2 Df, Qd)
  • Ketamine
Patient was hospitalized.

Exposure During Pregnancy, Liver Function Test Abnormal
Patient was taking Cymbalta. Patient felt the following Cymbalta side effects: exposure during pregnancy, liver function test abnormal on Feb 24, 2014 from US Additional patient health information: Female , 32 years of age, weighting 170.4 lb, was diagnosed with and. Cymbalta dosage: 30 Mg, Qd.
Multiple prescriptions taken:
  • Mononessa
  • Naproxen (500 Mg, Prn)
  • Lortab /00607101/ (500 Mg, Prn)


Transient Ischaemic Attack
Adverse event was reported on Feb 21, 2014 by a Male taking Cymbalta (Dosage: 60 Mg, Qd) was diagnosed with and. Location: US , 79 years of age, After Cymbalta was administered, patient encountered several Cymbalta side effects: transient ischaemic attack.

Pneumonia, Gynaecomastia, Hepatic Function Abnormal
on Feb 21, 2014 Male from JP , 47 years of age, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: pneumonia, gynaecomastia, hepatic function abnormal. Cymbalta dosage: 60 Mg, Qd.
Associated medications used:
  • Brotizolam (Unk)
  • Rohypnol (Unk)
  • Tetramide (Unk)
  • Gaster /00706001/ (Unk)


Somnolence, Nausea, Weight Increased, Asthenia, Hyperhidrosis, Hypertension, Initial Insomnia
on Feb 19, 2014 Female from US , 52 years of age, weighting 140.0 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: somnolence, nausea, weight increased, asthenia, hyperhidrosis, hypertension, initial insomnia. Cymbalta dosage: 1 Pill.

Dyspnoea, Tremor, Sleep Disorder, Mood Swings, Mental Impairment, Bipolar Disorder
Patient was taking Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: dyspnoea, tremor, sleep disorder, mood swings, mental impairment, bipolar disorder on Feb 19, 2014 from US Additional patient health information: Female , 48 years of age, weighting 336.6 lb, was diagnosed with and. Cymbalta dosage: N/A.

Hepatic Enzyme Increased
Adverse event was reported on Feb 20, 2014 by a Male taking Cymbalta (Dosage: N/A) was diagnosed with and. Location: CA , 54 years of age, Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: hepatic enzyme increased.

Cerebral Thrombosis, Urinary Tract Infection, Dysphagia
on Feb 20, 2014 Female from BR , 73 years of age, weighting 132.3 lb, was diagnosed with and was treated with Cymbalta. Patient felt the following Cymbalta side effects: cerebral thrombosis, urinary tract infection, dysphagia. Cymbalta dosage: 60 Mg, Qd.

Chronic Obstructive Pulmonary Disease, Bronchitis Viral, Respiratory Acidosis, Night Sweats
on Mar 11, 2014 Female from LB , 70 years of age, was diagnosed with and was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: chronic obstructive pulmonary disease, bronchitis viral, respiratory acidosis, night sweats. Cymbalta dosage: 60 Mg, Each Evening. Patient was hospitalized.

Oedema Peripheral, Movement Disorder, Hypertension, Dysuria
Patient was taking Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: oedema peripheral, movement disorder, hypertension, dysuria on Mar 20, 2014 from GR Additional patient health information: Male , 78 years of age, was diagnosed with and. Cymbalta dosage: 30 Mg, Qd.
Associated medications used:

Colitis
Adverse event was reported on Feb 20, 2014 by a Female taking Cymbalta (Dosage: N/A) was diagnosed with and. Location: DE , 43 years of age, Patient felt the following Cymbalta side effects: colitis.
Multiple prescriptions taken:

Suicidal Ideation
on Feb 18, 2014 Male from US , 53 years of age, was treated with Cymbalta. After Cymbalta was administered, patient encountered several Cymbalta side effects: suicidal ideation. Cymbalta dosage: Over 1st Month.

Paraesthesia, Mood Swings, Product Substitution Issue
on Feb 18, 2014 Female from US , 44 years of age, weighting 200.0 lb, was diagnosed with and was treated with Cymbalta. Directly after, patient experienced the unwanted or unexpected Cymbalta side effects: paraesthesia, mood swings, product substitution issue. Cymbalta dosage: N/A.

Page 1 of 575 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Cymbalta

Find Out How to Take Cymbalta

Discuss Cymbalta Side Effects

Did You Have a Cymbalta Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Cymbalta for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

Alternative CYMBALTA Names:DULOXETIN

Active Ingredient: DULOXETIN

Cymbalta Dosage, Warnings, Usage.

Side Effects reported to FDA: 14373

Cymbalta safety alerts: 2005

Reported deaths: 928

Reported hospitalizations: 4360

Cymbalta (duloxetine) Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications

Audience: Neuropsychiatric healthcare professionals and consumers

[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject of a June 30, 2005 Public Health Advisory issued about the risk of suicidality (suicidal thinking or behavior) in adults being treated with antidepressant medications.

[Posted 07/01/2005] In response to recent scientific publications that report the possibility of increased risk of suicidal behavior in adults treated with antidepressants, the FDA has issued a Public Health Advisory to update patients and healthcare providers with the latest information on this subject. Even before the publication of these recent reports, FDA had already begun the process of reviewing available data to determine whether there is an increased risk of suicidal behavior in adults taking antidepressants. The Agency has asked manufacturers to provide information from their trials using an approach similar to that used in the evaluation of the risk of suicidal behavior in the pediatric population taking antidepressants. This effort will involve hundreds of clinical trials and may take more than a year to complete.

[July 08, 2005 - Healthcare Professional and Patient Information Sheets - FDA]
[June 30, 2005 - Public Health Advisory - FDA]
[June 30, 2005 - Drug Information Page - FDA]

Latest Cymbalta clinical trials